These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12966336)

  • 1. Pharmacological and cultural considerations in alcohol treatment clinical trials: issues in clinical research related to race and ethnicity.
    Taylor RE
    Alcohol Clin Exp Res; 2003 Aug; 27(8):1345-8. PubMed ID: 12966336
    [No Abstract]   [Full Text] [Related]  

  • 2. Subjective response as a consideration in the pharmacogenetics of alcoholism treatment.
    Roche DJ; Ray LA
    Pharmacogenomics; 2015; 16(7):721-36. PubMed ID: 25950242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics in psychiatry: clinical issues to be considered.
    Licinio J; Wong ML
    Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
    [No Abstract]   [Full Text] [Related]  

  • 4. Issues involved in the accrual of respondents.
    Koop PM
    Can Oncol Nurs J; 2001; 11(4):170-1. PubMed ID: 11842448
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98.
    Humphreys K; Weingardt KR; Horst D; Joshi AA; Finney JW
    Addiction; 2005 Sep; 100(9):1249-57. PubMed ID: 16128714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized medicine prompts push to redesign clinical trials.
    Singer E
    Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
    [No Abstract]   [Full Text] [Related]  

  • 7. A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.
    Becker RC
    J Thromb Thrombolysis; 2008 Jun; 25(3):300-2. PubMed ID: 18470653
    [No Abstract]   [Full Text] [Related]  

  • 8. Attending to the role of race/ethnicity in family violence research.
    Malley-Morrison K; Hines DA
    J Interpers Violence; 2007 Aug; 22(8):943-72. PubMed ID: 17709804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of alcoholism with lysergide. Comment on the article by Smart et al., with special reference to issues of responsibility in research reporting.
    MacLean JR; Wilby WE
    Q J Stud Alcohol; 1967 Mar; 28(1):140-6. PubMed ID: 5339891
    [No Abstract]   [Full Text] [Related]  

  • 10. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
    Caulfield T
    Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
    [No Abstract]   [Full Text] [Related]  

  • 11. Musings on participation in health research and the recruitment process: it is not always about the numbers.
    Gignac MA
    Arthritis Rheum; 2007 Feb; 57(1):3-5. PubMed ID: 17266069
    [No Abstract]   [Full Text] [Related]  

  • 12. Overcoming challenges of using blood samples with gene expression microarrays to advance patient stratification in clinical trials.
    McPhail S; Goralski TJ
    Drug Discov Today; 2005 Nov; 10(22):1485-7. PubMed ID: 16257365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unicenter versus multicenter clinical trials].
    Nogueira de Rojas JR
    Rev Invest Clin; 1990 Jul; 42 Suppl():39-42. PubMed ID: 19256132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological issues in clinical trials of drug and behavior therapies.
    Holroyd KA; Powers SW; Andrasik F
    Headache; 2005 May; 45(5):487-92. PubMed ID: 15953265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in clinical trials of prophylaxis of fungal infections.
    Powers JH
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S211-7. PubMed ID: 15546120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics: the bioethical problem of DNA investment banking.
    Corrigan OP; Williams-Jones B
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):550-65. PubMed ID: 16980194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.
    Wang SJ
    Pharm Stat; 2007; 6(4):283-96. PubMed ID: 17957727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accrual issues in genitourinary cancer clinical trials.
    Lara PN; de Vere White R
    Urol Oncol; 2006; 24(5):379-83. PubMed ID: 16962485
    [No Abstract]   [Full Text] [Related]  

  • 20. Race and ethnicity in the era of emerging pharmacogenomics.
    Harty L; Johnson K; Power A
    J Clin Pharmacol; 2006 Apr; 46(4):405-7. PubMed ID: 16554447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.